Case series, chemotherapy-induced cardiomyopathy: mind the family history!
Setareh Moghadasi(Myriad (Germany)), Daniela Q.C.M. Barge‐Schaapveld(Leiden University), Judith R. Kroep(Leiden University Medical Center), Rienke De Fijn(Leiden University Medical Center), Saskia L.M.A. Beeres(Leiden University Medical Center), Jan D.H. Jongbloed(University Medical Center Groningen), Ronald H. Lekanne Deprez(Erasmus University Rotterdam), Djike Josephus Jitta, M. Louisa Antoni(Leiden University Medical Center), Mariëlle J.M. de Vreede(Medisch Centrum Haaglanden), Yvonne J. Vos(University Medical Center Groningen), Hennie Bikker(Amsterdam University Medical Centers)
Cited by 9
Related Papers
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
|European Journal of Cancer|2011|464
Outcome in Phospholamban R14del Carriers
|Circulation Cardiovascular Genetics|2014|190
A mutation update for the <i>FLNC</i> gene in myopathies and cardiomyopathies
|Human Mutation|2020|187
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
|The Lancet Oncology|2017|158
Subcellular sites for bacterial protein export
|Molecular Microbiology|2004|156